General Information of Drug (ID: DMM397E)

Drug Name
Ygalo
Indication
Disease Entry ICD 11 Status REF
Multiple myeloma 2A83 Phase 2 [1]
Cross-matching ID
TTD ID
D01CBE

References

1 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)